FDA advisory committee vote 16-0 for first even gene therapy for rare blindness – Gears Of Biz
|
FDA advisory committee vote 16-0 for first even gene therapy for rare blindness
Gears Of Biz The Cellular, Tissue and Gene Therapies Advisory Committee voted 16-0 to recommend this new therapy. The FDA usually accepts the recommendations from its advisory committee. If so, this could be the first one time gene therapy approved for an inherited … |
